5,185 followers
conclusion:MVC/DRV/r 150/800/100 mg once daily has potential 4 tx naive patients w R5 HIV-1 #maraviroc #ccr5 $cydy http://t.co/6jVmhth4Dv
Virologic Response, Early HIV-1 Decay, and Maraviroc Pharmacokinetics With the Nucleos(t)ide-Free Regimen of MaravIroc Plus Darunavir/Ritonavir in a Pilot Study
Overview of attention for article published in JAIDS: Journal of Acquired Immune Deficiency Syndromes, October 2013